Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

The Independence Gallery in downtown Loveland will once again be featuring art from creators worldwide, all to raise money to help medical research. The “65 Roses for Cystic Fibrosis” art show will ...

AI can summarize doctor-patient interactions, helping physicians produce visit notes for records and follow-up care. LLMs can even do this in the doctor’s voice. It’s not flawless, though.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

ITM announces positive Phase 3 results for ITM-11 in neuroendocrine tumours, paving the way for a potential new treatment ...

Gigi Moore’s tumor is caused by Zollinger-Ellison Syndrome, a rare cancer mostly found in men over 50. Since her diagnosis, James has been right by her side.

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia with a reliable supply of Gadolinium-160 (Gd-160). This critical ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LNTH stock, giving a Buy rating yesterday.Invest with Confidence: ...